Department of Internal Medicine, Nephrology, UT Southwestern Medical Center, Dallas, Texas, USA.
Department of Internal Medicine, Nephrology, UT Southwestern Medical Center, Dallas, Texas, USA.
Kidney Int. 2023 Jan;103(1):87-99. doi: 10.1016/j.kint.2022.08.039. Epub 2022 Oct 22.
Widespread aberrant gene expression is a pathological hallmark of polycystic kidney disease (PKD). Numerous pathogenic signaling cascades, including c-Myc, Fos, and Jun, are transactivated. However, the underlying epigenetic regulators are poorly defined. Here we show that H3K27ac, an acetylated modification of DNA packing protein histone H3 that marks active enhancers, is elevated in mouse and human samples of autosomal dominant PKD. Using comparative H3K27ac ChIP-Seq analysis, we mapped over 16000 active intronic and intergenic enhancer elements in Pkd1-mutant mouse kidneys. We found that the cystic kidney epigenetic landscape resembles that of a developing kidney, and over 90% of upregulated genes in Pkd1-mutant kidneys are co-housed with activated enhancers in the same topologically associated domains. Furthermore, we identified an evolutionarily conserved enhancer cluster downstream of the c-Myc gene and super-enhancers flanking both Jun and Fos loci in mouse and human models of autosomal dominant PKD. Deleting these regulatory elements reduced c-Myc, Jun, or Fos abundance and suppressed proliferation and 3D cyst growth of Pkd1-mutant cells. Finally, inhibiting glycolysis and glutaminolysis or activating Ppara in Pkd1-mutant cells lowerd global H3K27ac levels and its abundance on c-Myc enhancers. Thus, our work suggests that epigenetic rewiring mediates the transcriptomic dysregulation in PKD, and the regulatory elements can be targeted to slow cyst growth.
广泛的异常基因表达是多囊肾病 (PKD) 的病理标志。许多致病信号级联反应,包括 c-Myc、Fos 和 Jun,都被反式激活。然而,潜在的表观遗传调节因子定义不佳。在这里,我们表明 H3K27ac,一种乙酰化的 DNA 包装蛋白组蛋白 H3 的修饰,标记活跃的增强子,在常染色体显性 PKD 的小鼠和人类样本中升高。使用比较 H3K27ac ChIP-Seq 分析,我们在 Pkd1 突变小鼠肾脏中绘制了超过 16000 个活跃的内含子和基因间增强子元件。我们发现囊性肾脏表观遗传景观类似于发育中的肾脏,并且 Pkd1 突变肾脏中上调的基因超过 90%与同一拓扑相关域中的激活增强子共同存在。此外,我们在常染色体显性 PKD 的小鼠和人类模型中鉴定了一个位于 c-Myc 基因下游的进化保守的增强子簇和围绕 Jun 和 Fos 基因座的超级增强子。删除这些调节元件可降低 c-Myc、Jun 或 Fos 的丰度,并抑制 Pkd1 突变细胞的增殖和 3D 囊肿生长。最后,在 Pkd1 突变细胞中抑制糖酵解和谷氨酰胺分解或激活 Ppara 降低了全局 H3K27ac 水平及其在 c-Myc 增强子上的丰度。因此,我们的工作表明,表观遗传重布线介导了 PKD 中的转录组失调,并且可以靶向调节元件来减缓囊肿生长。